Rankings
▼
Calendar
PEPG
PepGen Inc.
$435M
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$7M
Net Income
-$7M
EPS (Diluted)
$-0.32
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$669,000
Balance Sheet
Total Assets
$144M
Total Liabilities
$11M
Stockholders' Equity
$133M
Cash & Equivalents
$133M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$29,000
+100.0%
Operating Income
-$7M
-$791,000
-811.6%
Net Income
-$7M
-$797,000
-796.4%
← FY 2021
All Quarters
Q1 2022 →
PEPG Q4 2021 Earnings — PepGen Inc. Revenue & Financial Results | Market Cap Arena